Short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer

Short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer

BackgroundThe aim of this study was to explore the short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer (ER).MethodsEighty-eight patients with ER cancer and 82 healthy controls who had completed a full course of inactivat...

Full description

Bibliographic Details
Main Authors: Rui Song, Li Liu, Qingbo Pan, Jin Liu, Jiahe Tan, Juan Deng, Qin Deng, Zijin Lin, Min Chen, Mingli Peng, Hong Ren, Jia Ming
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
cancer
COVID-19
SARS-COV-2
vaccine
memory B cells
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1028246/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1028246/full

Similar Items